Provided by Tiger Trade Technology Pte. Ltd.

DaVita HealthCare Partners

181.33
-1.6800-0.92%
Post-market: 180.62-0.7100-0.39%17:47 EDT
Volume:565.27K
Turnover:102.65M
Market Cap:11.64B
PE:14.95
High:184.41
Open:183.62
Low:180.47
Close:183.01
52wk High:247.49
52wk Low:101.00
Shares:64.20M
Float Shares:32.63M
Volume Ratio:0.95
T/O Rate:1.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):12.13
EPS(LYR):9.84
ROE:88.48%
ROA:7.52%
PB:-15.22
PE(LYR):18.43

Loading ...

DaVita publishes 2025 annual report

Reuters
·
May 05

DaVita Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
May 02

DaVita Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 01

Earning Preview: DaVita HealthCare Partners this quarter’s revenue is expected to increase by 4.66%, and institutional views are bullish

Earnings Agent
·
Apr 28

Press Release: Honeywell Announces Board of Directors for Honeywell Aerospace

Dow Jones
·
Apr 28

DaVita Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Apr 23

Veterans still battling with DVA claims system

prnewswire
·
Apr 22

DaVita schedules first-quarter results conference call

Reuters
·
Apr 21

DaVita Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 17

Is It Time To Revisit DaVita (DVA) After Mixed Share Price Performance?

Simply Wall St.
·
Apr 12

DaVita Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 10

California law limiting dialysis providers' profits voided by US appeals court

Reuters
·
Apr 08

DaVita Inc. Stock Advances 3.1%, Outperforms Peers

Dow Jones
·
Apr 07

Is DaVita’s (DVA) AI-Driven Home Dialysis Push Redefining Its Long-Term Competitive Moat?

Simply Wall St.
·
Apr 04

DaVita Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 26

AllianceBernstein Global High Income Fund Inc. Publishes Report; NAV $11.42

Reuters
·
Mar 24

DaVita reports 9% Total Quality Score improvement and more than USD 200 million in CKCC shared savings

Reuters
·
Mar 19

DaVita Mixes Strong Value Signals With Distress Score And Insider Selling

Simply Wall St.
·
Mar 18

Alebund Pharmaceuticals Announces Collaboration and License Agreement with R1 Therapeutics for AP306

prnewswire
·
Mar 17

BRIEF-R1 Therapeutics Announces Launch With An Oversubscribed $77.5 Million Series A Financing

Reuters
·
Mar 17